Randomization and treatment. A total of 182 patients completed the induction therapy as per protocol. Among the 6 patients who did not complete the induction therapy, 1 patient in the VEN-DEC group did not undergo reinduction therapy owing to a SAE. In the IA-12 group, 3 patients did not undergo reinduction owing to SAEs, and 2 were withdrawn by their physicians.